Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from JBM (Healthcare) Ltd. ( (HK:2161) ) is now available.
JBM (Healthcare) Limited has announced the re-designation of Mr. Sum Kwong Yip, Derek, and Mr. Yim Chun Leung from non-executive to executive directors, effective June 12, 2025. This move is expected to enhance the company’s strategic direction and operational management, leveraging the extensive experience of both individuals in the pharmaceutical and corporate finance fields.
More about JBM (Healthcare) Ltd.
JBM (Healthcare) Limited operates in the healthcare industry, focusing on pharmaceutical products and services. The company is involved in strategic planning and development within the pharmaceutical sector, leveraging extensive experience in sales and corporate management.
Average Trading Volume: 1,275,497
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.13B
For detailed information about 2161 stock, go to TipRanks’ Stock Analysis page.